Mounjaro (Tirzepatide) is the newest generation injectable medication
Cagrilintide is a long-acting analog of the pancreatic hormone amylin, developed by Novo Nordisk through fatty acid acylation to enable once-weekly subcutaneous dosing
instead, it promotes the efficient utilization of existing fat stores as a fuel source
In contrast, the STEP 1 trial for semaglutide showed a mean weight loss of 14.9% over 68 weeks
In contrast, IV drip and IV push involve the direct administration of glutathione into the bloodstream
Supports Anti-Aging and Longevity As we age, GH levels decline, contributing to: Increased body fat Decreased muscle mass Slower recovery Reduced vitality A review by Walker & Hoffman, Clinical Interventions in Aging (2012) showed that restoring GH levels helps improve body composition, skin tone, and overall vitality in aging adults